Pilot Study in Order to Evaluate Disconfort Among Outpatients Using actiTENS for Neuropathic Pain vs TENS ECO 2.
NCT ID: NCT03877016
Last Updated: 2023-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2019-09-17
2021-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective is to evaluate and to compare the use of actiTENS, with TENS Eco 2, the classical device in patients with chronic neuropathic pain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tonic Versus Burst DR(TM) Epidural Motor Cortex Stimulation for Neuropathic Pain
NCT05984329
Evaluation of Endogenous Pain Modulation Mechanisms With Transcutaneous Electrical Nerve Stimulation
NCT04236570
Transcutaneous vs Percutaneous Electrical Stimulation of the Radial Nerve
NCT07247721
Pain Reducing Effect of Transcutaneous Electrical Nerve Stimulation in Patients With Chronic Low Back Pain or Lumbo-radiculalgia
NCT00452010
Effectiveness of Ecoguided Percutaneous Neuromodulation of the Multipurpose Musculature of L-3 in Non-specific Chronic Lumbar Pain.
NCT03738748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TENS Eco2
TENS Eco2 is the classical device in patients with chronic neuropathic pain
TENS
TENS Eco2 or actiTENS, both admitted and reimbursed in FRANCE according to regulation
actiTENS
ActiTENS is a new TENS device, that seems less cotraining.
TENS
TENS Eco2 or actiTENS, both admitted and reimbursed in FRANCE according to regulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TENS
TENS Eco2 or actiTENS, both admitted and reimbursed in FRANCE according to regulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient covered by national health insurance
* Patient able to express consent
* Patient with neuropathic pain with DN4 (Douleur Neuropathique 4 Questions) \> or = 4/10.
* Actual or potential neurologic lesion
* Patient still using a TENS device
Exclusion Criteria
* Modification of the reatment in the next two motnhs
* Other study ongoing for the patient
* Medical contraindication for TENS
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric SERRA, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Amiens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens Picardie
Amiens, , France
CHD La Roche Sur Yon
La Roche-sur-Yon, , France
CHU de Nantes
Nantes, , France
APHP - Hopital Saint Antoine
Paris, , France
CHU de Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2018_843_0028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.